We are live on ! Find out more
THC icon

Tenet Healthcare

680 hedge funds and large institutions have $17B invested in Tenet Healthcare in 2025 Q3 according to their latest regulatory filings, with 128 funds opening new positions, 207 increasing their positions, 260 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 128 | Existing positions closed: 64

27% more call options, than puts

Call options by funds: $397M | Put options by funds: $313M

11% more capital invested

Capital invested by funds: $15.2B → $17B (+$1.74B)

9% more funds holding

Funds holding: 626680 (+54)

1.41% more ownership

Funds ownership: 93.2%94.61% (+1.4%)

20% less repeat investments, than reductions

Existing positions increased: 207 | Existing positions reduced: 260

28% less funds holding in top 10

Funds holding in top 10: 1813 (-5)

Holders
680
Holders Change
+54
Holders Change %
+8.63%
% of All Funds
8.93%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.17%
New
128
Increased
207
Reduced
260
Closed
64
Calls
$397M
Puts
$313M
Net Calls
+$84M
Net Calls Change
-$13.9M
Name Holding Trade Value Shares
Change
Change in
Stake
FRM
276
Fox Run Management
Connecticut
$1.75M +$1.29M +7,282 +539%
LOIP
277
Live Oak Investment Partners
Texas
$1.74M +$27.7K +156 +2%
FM
278
Foster & Motley
Ohio
$1.72M -$76.3K -430 -5%
SCM
279
Sterling Capital Management
North Carolina
$1.71M -$126K -710 -8%
US Bancorp
280
US Bancorp
Minnesota
$1.69M -$177 -1 -0%
LCGC
281
Legacy Capital Group California
California
$1.67M -$12.8K -72 -0.9%
CCIA
282
Campbell & Co Investment Adviser
Maryland
$1.65M +$1.44M +8,115 New
QCG
283
Quadrant Capital Group
Ohio
$1.64M -$23.8K -134 -2%
Federated Hermes
284
Federated Hermes
Pennsylvania
$1.6M -$138K -779 -9%
Simplex Trading
285
Simplex Trading
Illinois
$1.6M -$1.28M -7,220 -48%
TRCT
286
Tower Research Capital (TRC)
New York
$1.55M +$934K +5,266 +221%
First Eagle Investment Management
287
First Eagle Investment Management
New York
$1.53M -$425K -2,394 -24%
STA
288
Summit Trail Advisors
New York
$1.51M +$275K +1,551 +26%
PCM
289
Prelude Capital Management
New York
$1.5M -$468K -2,635 -26%
FPAS
290
Focus Partners Advisor Solutions
Missouri
$1.5M +$688K +3,875 +105%
CG
291
Caprock Group
Idaho
$1.48M +$1.43M +8,042 New
GCM
292
Graham Capital Management
Connecticut
$1.47M -$856K -4,826 -40%
QCM
293
QRG Capital Management
Illinois
$1.45M -$2.43M -13,722 -66%
Qube Research & Technologies (QRT)
294
Qube Research & Technologies (QRT)
United Kingdom
$1.45M +$1.26M +7,129 New
BJL
295
Brighton Jones LLC
Washington
$1.44M +$541K +3,050 +75%
ASN
296
Advisory Services Network
Georgia
$1.43M +$42K +237 +3%
Credit Agricole
297
Credit Agricole
France
$1.37M +$1.2M +6,759 New
SAM
298
Securian Asset Management
Minnesota
$1.34M -$81.1K -457 -6%
PWG
299
Portside Wealth Group
Utah
$1.32M -$14.9K -84 -1%
PAP
300
Persistent Asset Partners
Hong Kong
$1.31M -$1.08M -6,065 -48%

THC Hedge Fund Activity: Q3 2025 in Review

680 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Tenet Healthcare (THC) for Q3 2025, worth a combined $17B — up 11% from $15.2B a quarter earlier.

Buyers outnumbered sellers: 128 funds opened new THC positions and 64 closed out — a net gain of 64 holders — while 207 added to existing stakes and 260 trimmed.

The largest buyer was Eminence Capital, opening a new position worth an estimated $197M. The largest seller was Citadel Advisors, cutting an estimated $137M.

  • 680 institutional investors held Tenet Healthcare (THC) as of Q3 2025, up from 626 in Q2 2025.
  • Funds reported $17B of Tenet Healthcare stock for Q3 2025, up 11% quarter-over-quarter.
  • 128 funds opened new Tenet Healthcare positions in Q3 2025 and 64 closed out, a net change of +64 holders.
  • The largest Tenet Healthcare buyer in Q3 2025 was Eminence Capital, an estimated $197M added.
  • The largest Tenet Healthcare seller in Q3 2025 was Citadel Advisors, an estimated $137M sold.

Based on aggregated 13F filings for Q3 2025.